Related references
Note: Only part of the references are listed.A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Sven M. Francque et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
Nadine Gehrke et al.
GASTROENTEROLOGY (2020)
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter et al.
GASTROENTEROLOGY (2020)
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD
James M. Paik et al.
HEPATOLOGY (2020)
Nonalcoholic Steatohepatitis: A Review
Adam C. Sheka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease
Leonard Kaps et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
Christian Labenz et al.
HEPATOLOGY COMMUNICATIONS (2020)
Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation
Marko Salmi et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH)
Manca Povsic et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B
Juan Li et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2017)
Vascular Adhesion Protein-1 Blockade Suppresses Ocular Inflammation After Retinal Laser Photocoagulation in Mice
Takashi Matsuda et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model
A. G. Jarnicki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Drug-Induced Liver Injury in Patients With Preexisting Chronic Liver Disease in Drug Development: How to Identify and Manage?
Naga Chalasani et al.
GASTROENTEROLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Vascular adhesion protein 1 in nonalcoholic steatohepatitis: A novel biomarker?
Natalie J. Torok
HEPATOLOGY (2015)
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic
Chris J. Weston et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
MCPMod: AnRPackage for the Design and Analysis of Dose-Finding Studies
Björn Bornkamp et al.
Journal of Statistical Software (2015)
Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration
Heidi C. Schilter et al.
RESPIRATORY RESEARCH (2015)
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
Kenneth Cusi et al.
JOURNAL OF HEPATOLOGY (2014)
Model-based dose finding under model uncertainty using general parametric models
Jose Pinheiro et al.
STATISTICS IN MEDICINE (2014)
Evolving therapies for liver fibrosis
Detlef Schuppan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
VAP-1/SSAO Plasma Activity and Brain Expression in Human Hemorrhagic Stroke
Mar Hernandez-Guillamon et al.
CEREBROVASCULAR DISEASES (2012)
Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis
A. B. Jazwinski et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Localization of vascular adhesion protein-1 (VAP-1) in the human eye
Lama Almulki et al.
EXPERIMENTAL EYE RESEARCH (2010)
Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes
Kousuke Noda et al.
EXPERIMENTAL EYE RESEARCH (2009)
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
W. Ray Kim et al.
HEPATOLOGY (2008)
Design and analysis of dose-finding studies combining multiple comparisons and modeling procedures
Jose Pinheiro et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2006)
Recruitment of lymphocytes to the human liver
PF Lalor et al.
IMMUNOLOGY AND CELL BIOLOGY (2002)
Circulating soluble vascular adhesion protein 1 accounts fear the increased serum monoamine oxidase activity in chronic liver disease
R Kurkijärvi et al.
GASTROENTEROLOGY (2000)
Share Paper
